DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Zydus Lifesciences Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·24 Oct 2026, 6:01 am

Zydus Lifesciences

Zydus Lifesciences has announced that it will hold an institutional investor meet and conference call. This event is a standard corporate procedure where the company management discusses its business strategy, product pipeline, and future outlook with analysts and investors. It provides a platform for the company to communicate directly with the financial community.

For investors, these meetings are often a key source of information. They can offer clarity on the company's growth plans, upcoming product launches, and operational performance. By listening to the management's commentary, investors can better assess the company's trajectory and make more informed decisions regarding their holdings.

Moving forward, investors should pay close attention to the management's guidance on sales growth, profitability, and key pipeline developments discussed during the call. Any updates on regulatory approvals or strategic partnerships could also have a significant impact on the stock's performance.